Phyllis L. Gan
Singapore, 117600, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Formoterol, the Most Effective Bronchodilator, Has No Anti-Inflammatory nor Metabolic Modulatory Effects in Severe Asthma Induced by Aspergillus fumigatus.
Journal: ACS pharmacology & translational science
Published: November 15, 2024
A combination of alveolar type 2-specific p38α activation with a high-fat diet increases inflammatory markers in mouse lungs.
Journal: The Journal of biological chemistry
Published: July 09, 2024
Targeting reprogrammed metabolism as a therapeutic approach for respiratory diseases.
Journal: Biochemical pharmacology
Published: January 20, 2024
Targeting the renin angiotensin system for respiratory diseases.
Journal: Advances in pharmacology (San Diego, Calif.)
Published: July 31, 2023
Degradation of MK2 with natural compound andrographolide: A new modality for anti-inflammatory therapy.
Journal: Pharmacological research
Published: May 05, 2023
Angiotensin II type-2 receptor activation in alveolar macrophages mediates protection against cigarette smoke-induced chronic obstructive pulmonary disease.
Journal: Pharmacological research
Published: July 17, 2022
Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma.
Journal: The Korean journal of internal medicine
Published: April 07, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026